{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:46:39Z","timestamp":1792431999495,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"am","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.tmaid.2020.101873","type":"journal-article","created":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T03:21:27Z","timestamp":1599535287000},"page":"101873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"special_numbering":"C","title":["Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation"],"prefix":"10.1016","volume":"37","author":[{"given":"Mathieu","family":"Gendrot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Andreani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Boxberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Jardot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Fonta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Le Bideau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Duflot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Mosnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Rolland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Bogreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Hutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8006-7704","authenticated-orcid":false,"given":"Bernard","family":"La Scola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pradines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmaid.2020.101873_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tmaid.2020.101873_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41421-020-0147-1","article-title":"Comparative genetic abalysis of the novel coronavirus (2019-nCoV\/SARS-CoV-2) receptor ACE2 in different populations","volume":"6","author":"Cao","year":"2020","journal-title":"Cell Dicov"},{"key":"10.1016\/j.tmaid.2020.101873_bib3","doi-asserted-by":"crossref","first-page":"101658","DOI":"10.1016\/j.tmaid.2020.101658","article-title":"Repurposing antimalarials and other drugs for COVID-19","volume":"34","author":"Schlagenhauf","year":"2020","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101873_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.tmaid.2020.101873_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCov) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.tmaid.2020.101873_bib6","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/cid\/ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"71","author":"Yao","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101873_bib7","doi-asserted-by":"crossref","first-page":"104228","DOI":"10.1016\/j.micpath.2020.104228","article-title":"In vitro testing of hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect","volume":"145","author":"Andreani","year":"2020","journal-title":"Microb Pathog"},{"key":"10.1016\/j.tmaid.2020.101873_bib8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jcrc.2020.03.005","article-title":"A systematic review on the efficacy and safety of chloroquine for the treatment of COVIS-19","volume":"57","author":"Cortegiani","year":"2020","journal-title":"J Crit Care"},{"key":"10.1016\/j.tmaid.2020.101873_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: chloroquine phosphate has shown apparent efficacy in the treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci Trends"},{"key":"10.1016\/j.tmaid.2020.101873_bib10","doi-asserted-by":"crossref","first-page":"104762","DOI":"10.1016\/j.antiviral.2020.104762","article-title":"Of chloroquine and COVID-19","volume":"177","author":"Touret","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.tmaid.2020.101873_bib11","series-title":"Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial","author":"Chen","year":"2020"},{"key":"10.1016\/j.tmaid.2020.101873_bib12","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"56","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.tmaid.2020.101873_bib13","doi-asserted-by":"crossref","first-page":"101663","DOI":"10.1016\/j.tmaid.2020.101663","article-title":"Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: an observational study","volume":"34","author":"Gautret","year":"2020","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101873_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/jac\/48.2.179","article-title":"Ferrocene-chloroquine analogues as antimalarial agents: in vitro activity of ferrochloroquine against 103 Gabonese isolates of Plasmodium falciparum","volume":"48","author":"Pradines","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tmaid.2020.101873_bib15","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1021\/jm0601856","article-title":"Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities","volume":"49","author":"Biot","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.tmaid.2020.101873_bib16","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.1002\/chem.201800729","article-title":"Synthesis of artemisinin-derivated di\/tri-mers and dendrimers, investigation of their activity against P. falciparum and cytomegalovirus, and insights into their mechanisms of action","volume":"24","author":"Fr\u00f6lich","year":"2018","journal-title":"Chemistry"},{"key":"10.1016\/j.tmaid.2020.101873_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00288-18","article-title":"The artemisinin derivative artemisone is a potent inhibitor of human cytomegalovirus replication","volume":"62","author":"Oiknine-Djian","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tmaid.2020.101873_bib18","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1128\/AAC.00262-15","article-title":"Inhibition of human cytomegalovirus replication by artemisinins: effects mediated through cell cycle modulation","volume":"59","author":"Roy","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tmaid.2020.101873_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/095632020601700505","article-title":"Evaluation of immunomodulators, interferons and known in vitro SARS-CoV inhibitors for inhibition of SARS-CoV replication in BALB\/c mice","volume":"17","author":"Barnard","year":"2006","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.tmaid.2020.101873_bib20","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/CM9.0000000000000797","article-title":"Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus (2019-nCoV) related coronavirus model","volume":"133","author":"Fan","year":"2020","journal-title":"Chinese Med J"},{"key":"10.1016\/j.tmaid.2020.101873_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007890","article-title":"Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection","volume":"13","author":"Lane","year":"2019","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.tmaid.2020.101873_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.tmaid.2020.101873_bib23","doi-asserted-by":"crossref","first-page":"101632","DOI":"10.1016\/j.tmaid.2020.101632","article-title":"Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infection diseases referral hospital in Marseille, France, -January 31st to March 1st, 2020: a respiratory virus snapshot","author":"Amrane","year":"2020","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101873_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1051\/ata:2005025","article-title":"Les intoxications aigu\u00ebs \u00e0 la chloroquine: aspects cliniques et analytiques","volume":"17","author":"Servonnet","year":"2005","journal-title":"Ann Toxicol Anal"},{"key":"10.1016\/j.tmaid.2020.101873_bib25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/rheumatology\/15.3.235","article-title":"Chloroquine: a review","volume":"15","author":"Popert","year":"1976","journal-title":"Rheumatol Rehabil"},{"key":"10.1016\/j.tmaid.2020.101873_bib26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10787-015-0239-y","article-title":"Therapy and pharmacological properties of hydroxychloroquine and chloroquine in the treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases","volume":"23","author":"Rainsford","year":"2015","journal-title":"Inflammatopharmacol"},{"key":"10.1016\/j.tmaid.2020.101873_bib27","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jchromb.2017.11.026","article-title":"Simultaneous quantification of hydroxychloroquine and its metabolites in mouse blood and tissues using LC-ESI-MS\/MS: an application for pharmacokinetic studies","volume":"1072","author":"Chhonker","year":"2018","journal-title":"J Chromatogr Anal Technol Biomed Life Sci"},{"key":"10.1016\/j.tmaid.2020.101873_bib28","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1186\/s12936-016-1511-3","article-title":"A Phase II pilot trial to evaluate safety anf efficacy of ferroquine against early Plasmodium falciparum in a induced blood-stage malaria infection study","volume":"15","author":"McCarthy","year":"2016","journal-title":"Malar J"},{"key":"10.1016\/j.tmaid.2020.101873_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol J"},{"key":"10.1016\/j.tmaid.2020.101873_bib30","doi-asserted-by":"crossref","first-page":"105960","DOI":"10.1016\/j.ijantimicag.2020.105960","article-title":"Structural and molecular modeling studies reveals a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection","volume":"55","author":"Fantini","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.tmaid.2020.101873_bib31","article-title":"COVID-19: attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism","author":"Liu","year":"2020","journal-title":"ChemRxiv"},{"key":"10.1016\/j.tmaid.2020.101873_bib32","first-page":"55","article-title":"Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon gamma production by peripheral blood mononuclear cells","volume":"24","author":"Van den Borne","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.tmaid.2020.101873_bib33","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101873_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2558-4","article-title":"Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates","author":"Maisonnasse","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tmaid.2020.101873_bib35","doi-asserted-by":"crossref","first-page":"101738","DOI":"10.1016\/j.tmaid.2020.101738","article-title":"Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille, France","volume":"35","author":"Million","year":"2020","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101873_bib36","doi-asserted-by":"crossref","first-page":"101791","DOI":"10.1016\/j.tmaid.2020.101791","article-title":"Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine\/azithromycin and other regimens in Marseille, France: a retrospective analysis","volume":"36","author":"Lagier","year":"2020","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101873_bib37","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ijid.2020.06.099","article-title":"Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19","volume":"97","author":"Arshad","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101873_bib38","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.3947\/ic.2020.52.3.396","article-title":"Early hydroxychloroquine administration for rapid severe acute respiratory syndrome coronavirus 2 eradication","volume":"52","author":"Hong","year":"2020","journal-title":"Infect Chemother"},{"key":"10.1016\/j.tmaid.2020.101873_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.26193","article-title":"Hydroxychloroquine treatment in COVID-19: a descriptive observational analysis of 30 cases from a single center in Wuhan, China","author":"Xue","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.tmaid.2020.101873_bib40","first-page":"1","article-title":"Beneficial effects exerted by hydroxychloroquine in treating COVID-19 patients via protecting multiple organs","volume":"3","author":"Yu","year":"2020","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.tmaid.2020.101873_bib41","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2019014","article-title":"Hydroxychloroquine with or without azithromycin in mild-to-moderate Covid-19","author":"Cavalcanti","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2020.101873_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106136","article-title":"Effects of hydroxychloroquine on Covid-19 in intensive care unit patients: preliminary results","author":"Lopez","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.tmaid.2020.101873_bib43","article-title":"Compassionate use of hydroxychloroquine in clinical practice for patients with mild to severe Covid-19 in a French university hospital","author":"Paccoud","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101873_bib44","article-title":"Hydroxychloroquine for early treatment of adults with mild-Covid-19: a randomized-controlled trial","author":"Mitja","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101873_bib45","doi-asserted-by":"crossref","DOI":"10.4269\/ajtmh.20-0873","article-title":"Hydroxychloroquine in the treatment of COVID-19: a multicenter randomized controlled study","author":"Abd-Elsalam","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2020.101873_bib46","doi-asserted-by":"crossref","first-page":"105980","DOI":"10.1016\/j.ijantimicag.2020.105980","article-title":"Chloroquine as prophylactic agent against COVID-19?","volume":"55","author":"Gendrot","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.tmaid.2020.101873_bib47","author":"Gendrot"},{"key":"10.1016\/j.tmaid.2020.101873_bib48","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.trstmh.2009.10.001","article-title":"Doxycycline-chloroquine vs. doxycycline placebo for malaria prophylaxis in nonimmune soldiers: a double-blind randomized field trial in sub-Saharan Africa","volume":"104","author":"Michel","year":"2010","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2020.101873_bib49","doi-asserted-by":"crossref","first-page":"5114","DOI":"10.1128\/AAC.04957-14","volume":"59","author":"Adedeji","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tmaid.2020.101873_bib50","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.2042-7158.1988.tb05264.x","article-title":"Tissue distribution and excretion of amodiaquine in the rat","volume":"40","author":"Winstanley","year":"1988","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.tmaid.2020.101873_bib51","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2014.03.014","article-title":"Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity","volume":"106","author":"Boonyasuppayakorn","year":"2014","journal-title":"Antivir Res"},{"key":"10.1016\/j.tmaid.2020.101873_bib52","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1159\/000109767","article-title":"Antimalarial drug toxicity: a review","volume":"53","author":"Alkadi","year":"2004","journal-title":"Chemotherapy"},{"key":"10.1016\/j.tmaid.2020.101873_bib53","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/1475-2875-12-443","article-title":"Gender-specific distribution of mefloquine in the blood following the administration of therapeutic doses","volume":"12","author":"Wernsdorfer","year":"2013","journal-title":"Malar J"},{"key":"10.1016\/j.tmaid.2020.101873_bib54","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0379-0738(94)90376-X","article-title":"Mefloquine distribution in postmortem cases","volume":"68","author":"Jones","year":"1994","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.tmaid.2020.101873_bib55","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2310\/7060.2000.00002","article-title":"Neuropsychiatric problems in 2,500 long-term young travelers to the tropics","volume":"7","author":"Potasman","year":"2000","journal-title":"J Trav Med"},{"key":"10.1016\/j.tmaid.2020.101873_bib56","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s13318-014-0182-0","article-title":"Mass balance and metabolism of the antimalarial pyronaridine in healthy volunteers","volume":"40","author":"Morris","year":"2015","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.tmaid.2020.101873_bib57","doi-asserted-by":"crossref","first-page":"590707","DOI":"10.1155\/2010\/590707","article-title":"Absorption, distribution, excretion, and pharmacokinetics of 14C-pyronaridine tetraphosphate in male and female Sprague-Dawley rats","volume":"2010","author":"Park","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.tmaid.2020.101873_bib58","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1475-2875-11-270","article-title":"Review of pyronaridine ant-malarial properties and product characteristics","volume":"11","author":"Croft","year":"2012","journal-title":"Malar J"},{"key":"10.1016\/j.tmaid.2020.101873_bib59","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0169-4758(91)90267-R","article-title":"Pyronaridine: a new antimalarial drug","volume":"7","author":"Fu","year":"1991","journal-title":"Parasitol Today"},{"key":"10.1016\/j.tmaid.2020.101873_bib60","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.curtheres.2019.100567","article-title":"Pharmacokinetic parameters of quinine in healthy subjects and in patients with uncomplicated malaria in Nigeria: analysis of data using a population approach","volume":"91","author":"Adehin","year":"2019","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.tmaid.2020.101873_bib61","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.2042-7158.1981.tb13835.x","article-title":"Comparative uptake of quinine and quinidine in rat lung","volume":"33","author":"Minchin","year":"1981","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.tmaid.2020.101873_bib62","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12936-017-1698-y","article-title":"Artemether-lumefantrine and liver enzyme abnormalities in non-severe Plasmodium falciparum malaria in returned travellers: a retrospective comparative study with quinine-doxycycline in Portuguese centre","volume":"16","author":"Silva-Pinto","year":"2017","journal-title":"Malar J"},{"key":"10.1016\/j.tmaid.2020.101873_bib63","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/bcpt.12065","article-title":"Comparable lumefantrine oral bioavailability when co-administered with oil-fortified maize porridge or milk in healthy volunteers","volume":"113","author":"Mwebaza","year":"2013","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.tmaid.2020.101873_bib64","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s40261-015-0312-8","article-title":"Effect of food on the pharmacokinetics of piperaquine and dihydroartemisinin","volume":"35","author":"Reuter","year":"2015","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.tmaid.2020.101873_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2020.08.032","article-title":"Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: in vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate","author":"Gendrot","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101873_bib66","doi-asserted-by":"crossref","first-page":"104786","DOI":"10.1016\/j.antiviral.2020.104786","article-title":"Remdesivir, lopinavir, emetine, and homoharringtonine inhibits SARS-CoV-2 replication in vitro","volume":"178","author":"Choy","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.tmaid.2020.101873_bib67","article-title":"Hydroxychloroquine in the treatment of COVID-19: how to use it waiting for conclusive scientific evidence","author":"Cairoli","year":"2020","journal-title":"Med Clin"},{"key":"10.1016\/j.tmaid.2020.101873_bib68","article-title":"Chloroquine and hydroxychloroquine as a repurposed agent against COVID-19: a narrative review","author":"Acharya","year":"2020","journal-title":"Ther Adv Infect Dis"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893920303690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893920303690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:05:13Z","timestamp":1761487513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893920303690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":68,"alternative-id":["S1477893920303690"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2020.101873","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2020.101873","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101873"}}